FOR IMMEDIATE RELEASE II
Chief Executive Lawrence Ho will resume his duties on Monday, July 27, 2026. Following a successful recovery, Lawrence Ho will return to lead the company, while Pedin Xie will conclude the role of Acting Chief Executive.
Chief Executive Lawrence Ho will resume his duties on Monday, July 27, 2026. Following a successful recovery, Lawrence Ho will return to lead the company, while Pedin Xie will conclude the role of Acting Chief Executive.
Chief Executive will undergo surgery on Monday, July 19, 2026. Pedin Xie has been appointed Acting Chief Executive.